A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole From Subcutaneous Testosterone and Anastrozole (T+Ai) in Premenopausal Women
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Anastrozole/testosterone (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- Sponsors HAVAH Therapeutics
- 17 Apr 2018 Status changed from recruiting to completed.
- 27 Oct 2017 New trial record